Ciclosporin and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Ciclosporin (cyclosporine), especially for people who are female, 40-49 old, also take Advil, and have Erythema multiforme.

The phase IV clinical study analyzes which people have Blindness when taking Ciclosporin. It is created by eHealthMe based on reports of 3,560 people who have side effects when taking Ciclosporin from the FDA, and is updated regularly.

What is Ciclosporin?

Ciclosporin has active ingredients of cyclosporine. eHealthMe is studying from 3,571 Ciclosporin users. Check the latest studies of Ciclosporin.

What is Blindness?

Blindness is found to be associated with 1,509 drugs and 1,986 conditions by eHealthMe. Check the latest studies of Blindness.

On Jul, 10, 2026

3,560 people reported to have side effects when taking Ciclosporin.
Among them, 16 people (0.45%) have Blindness.

Among these 16 people:

What is the gender of people who have Blindness when taking Ciclosporin? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Blindness when taking Ciclosporin? *

What are other drugs people take besides Ciclosporin? *

Advil: 4 people, 25.00%
Triamcinolone: 1 person, 6.25%

What are other side effects people have besides Blindness? *

Visual Acuity Reduced (reduced clearness of vision): 6 people, 37.50%
Pneumonia: 5 people, 31.25%
Scedosporium Infection (a filamentous fungus which occasionally causes infections in humans): 5 people, 31.25%
Aphonia (inability to produce voice): 4 people, 25.00%
Depressive Symptom: 4 people, 25.00%
Fatigue (feeling of tiredness): 4 people, 25.00%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 4 people, 25.00%
Mobility Decreased (ability to move is reduced): 4 people, 25.00%
Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 25.00%
Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the eye): 4 people, 25.00%

What are the existing conditions these people have? *

Retinitis (inflammation of the retina in the eye): 4 people, 25.00%
Migraine (headache): 4 people, 25.00%
Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 25.00%
High Blood Pressure: 3 people, 18.75%
Bone Marrow Conditioning Regimen: 3 people, 18.75%
Aplastic Anemia: 2 people, 12.50%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 6.25%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 1 person, 6.25%
Joint Pain: 1 person, 6.25%
Immunodeficiency Disorders: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ciclosporin and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ciclosporin:

Ciclosporin (3,571 reports)

Blindness treatments and more:

Blindness (45,948 reports)

Browse all side effects of Ciclosporin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,509 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,986 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Ciclosporin) and Ciclosporin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.